Test/Investigation
ANCA
Site(s) or Laboratory offering Test/Investigation
NNUH (Immunology)
Units
IU/mL
Also Known as/Frequency of Test
Neutrophil Cytoplasmic Antibodies, MPO/PR3; c-ANCA; p-ANCA
Indications
Anti-MPO antibodies (often associated with a pANCA pattern): Commonly associated with microscopic polyangiitis (MPA) and rapidly progressive glomerulonephritis (RPGN). They are also found in approximately 60% of cases of eosinophilic granulomatosis with polyangiitis (EGPA). Anti-PR3 antibodies (often cANCA pattern): Most strongly associated with granulomatosis with polyangiitis (GPA), but may also occur in MPA and EGPA. New positive MPO/PR3 will have an ANCA test by indirect immunoflourescence.
Comments/Precautions
ANCA immunoflourescence is performed at the discretion of the laboratory and can be added in unusual cases of ANCA positivity.
Sample type
Serum
Turnaround times (TAT) Urgent/Routine/GP or OPD
3 working days
Reference intervals (adult unless stated)
MPO <3.5 IU/mL Negative
3.5 – 5.0 IU/mL Equivocal
>5.0 IU/mL Positive. PR3 <2.0 IU/mL Negative
2.0 – 3.0 IU/mL Equivocal
>3.0 IU/mL Positive
ANCA immunofluorescence Negative
If UKAS Accredited Test indicate at which site
Y NNUH